Established by Daiichi Sankyo Co., Ltd. in 2010, DAIICHI SANKYO ESPHA is a fabless manufacturer focused on the planning and sales of generics. It joined the Qol Group in April 2024.
Pharmaceutical Manufacturing Business
(Medical-Related Business)
We welcomed Fujinaga pharm Co., Ltd. and DAIICHI SANKYO ESPHA Co., Ltd. to the Qol Group in August 2019 and April 2024 respectively. Leveraging synergy with our core Pharmacy Business, we develop products that reflect patient feedback, putting ourselves in the shoes of all those who are coping with illness.
DAIICHI SANKYO ESPHA CO., LTD.
PointStrength in authorized generics (AGs)
Authorized generics are generic drugs with the same active and inactive ingredients and manufacturing methods as original drugs (brand-name drugs), manufactured with the brand company's permission and generic drugs that may be marketed by the brand company's licensee with the brand company's permission.
DAIICHI SANKYO ESPHA is one of the leading manufacturers of AGs in Japan based on revenue and the number of products handled*, and seeks to contribute to medical care through the provision of high quality, affordable AGs.
- *as of FY2022
Fujinaga Pharm Co., Ltd.
Fujinaga Pharm is a manufacturer of prescription pharmaceuticals founded in 1924.
It joined the Qol Group in August 2019, and has continued to grow steadily since then.
In 1943, Fujinaga Pharm became the first company in Japan to successfully synthesize and mass produce phenobarbital, which is still widely used today to treat psychiatric disorders. Meanwhile in the dermatology field, Fujinaga Pharm's Glyteer products have been widely used from 1926 to the present day. Going forward, Fujinaga Pharm will continue pursuing possibilities in the psychiatry and dermatology fields and other therapeutic fields, aiming to contribute to people's health and welfare.
